BARIATRICSEDITORIAL.COM

physicianeditorial.com

Sequenta Launches New Online Results Portal for Physicians – Physician Editorial

http://physicianeditorial.com/2014/12/04/sequenta-launches-new-online-results-portal-for-physicians

Medical Knowledge by the Experts. Sequenta Launches New Online Results Portal for Physicians. Secure, real-time access to ClonoSIGHT test results, order status, patient MRD trends. A fully functional demo of the ClonoSIGHT Secure Portal available at https:/ demo.clonosight.com, allows physicians to explore each feature of the portal. Physicians can also demo the portal at the 56th Annual Meeting of the American Society Hematology (Booth #1243). The portal was developed in collaboration wi...Sequenta’s Cl...

physicianeditorial.com

NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England – Physician Editorial

http://physicianeditorial.com/2014/11/27/nice-issues-final-positive-recommendation-for-national-commissioning-of-soliris-eculizumab-for-all-patients-with-ahus-in-england

Medical Knowledge by the Experts. NICE Issues Final Positive Recommendation for National Commissioning of Soliris (eculizumab) for All Patients with aHUS in England. Final Evaluation Determination Confirms that Soliris is a Very Effective Treatment for aHUS with Significant Value to Patients. Final Evaluation Determination Includes the Same Conditions Discussed in Draft Recommendation, Including Establishment of an Expert Center and a Robust System to Monitor Patients Receiving Treatment. As noted by NIC...

physicianeditorial.com

Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive Disorder – Physician Editorial

http://physicianeditorial.com/2015/01/06/alkermes-announces-positive-results-from-study-of-alks-5461-for-treatment-of-major-depressive-disorder

Medical Knowledge by the Experts. Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive Disorder. Safety and Tolerability Profile of ALKS 5461 Confirmed in FORWARD-1 Study, a Supportive Study in the FORWARD Phase 3 Pivotal Program. Dosing Regimen Confirmed; Efficacy Data Showed Statistically Significant Improvements in Depression Scores Beginning at Week One and Continuing Through Eight-Week Treatment Period. About the Phase 3 FORWARD Clinical Program. ALKS 5461 is...

physicianeditorial.com

Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia – Physician Editorial

http://physicianeditorial.com/2015/01/07/alkermes-announces-positive-results-of-phase-2-clinical-trial-of-alks-3831-in-schizophrenia

Medical Knowledge by the Experts. Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia. Once-Daily, Oral Product Candidate Showed Efficacy Equivalent to Olanzapine With Clinically Meaningful and Statistically Significant Lower Weight Gain in 300-Patient Study. Company Plans to Initiate Pivotal Development Program in 2015. Weight gain observed in the olanzapine-only arm was consistent with that reported in the olanzapine label. Additional analyses focused on those pa...

physicianeditorial.com

New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris® (eculizumab) Treatment – Physician Editorial

http://physicianeditorial.com/2014/12/08/new-data-presented-at-ash-annual-meeting-enhance-clinical-knowledge-of-ahus-and-pnh-and-underscore-the-effectiveness-of-soliris-eculizumab-treatment

Medical Knowledge by the Experts. New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris (eculizumab) Treatment. New Analyses Report Clinical Benefits of Ongoing Soliris Therapy in Children and Adults with aHUS With or Without Identified Genetic Mutations. Observational Data Highlight Importance of High Sensitivity Flow Cytometry to Enable Reliable Detection of PNH Cells. Eculizumab is an Effective Treatment for Atypical Hemolytic U...

physicianeditorial.com

Press Releases – Physician Editorial

http://physicianeditorial.com/category/press-releases

Medical Knowledge by the Experts. Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis. Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49. Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma. S-TRAC is the First RCC Trial of a Tyrosine Kinase Inhibitor to...

physicianeditorial.com

Hospitals – Physician Editorial

http://physicianeditorial.com/hospitals

Medical Knowledge by the Experts. Newfoundland and Labrador Establishing Provincial Telepathology Network. West Kendall Baptist Hospital First in the World to Scan Patients with GE’s New Revolution CT System. Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan. Agreement secures full Elekta solution across the McLaren enterprise STOCKHOLM, December 18, 2013 The ability to effectively manage data across disparate health systems to help drive quality care will...